7 chapters across the catalog
Antibiotic Resistance in China, Drug Development Stagnation
Dr. Sanjay Gupta discusses the role of bacterial infections and antibiotic resistance in China's respiratory illness surge. The hosts criticize pharmaceutical companies for halting antibiotic research in favor of more profitable vaccines and weight-loss drugs.
Researchers have used artificial intelligence to identify a new antibiotic effective against the drug-resistant bacteria Acinetobacter baumannii. The hosts critique the media's personification of bacteria as "smart" and clarify that the process is actually high-speed machine learning rather than true intelligence. While successful in mice, the drug faces years of human clinical trials and the challenge of pharmaceutical profitability.
Reports of "super gonorrhea" have resurfaced, highlighting the increasing resistance of the infection to standard antibiotics. The hosts note this is a recurring news story that has appeared several times over the last decade.
Antibiotic Production, Fermentation and Drug Resistance
The United States has largely ceased domestic production of antibiotics, outsourcing the process to China due to their expertise in fermentation. This economic shift has led to a reliance on imported antibiotic salts, which are then processed in India. Substandard generic doses are cited as a primary driver of global drug resistance, as patients receive ineffective levels of medication.
Antibiotic Resistance, Drug Company R&D Priorities
The CDC is warning of a highly resistant strain of E. coli found in a Pennsylvania woman. The discussion criticizes pharmaceutical companies like Pfizer for abandoning antibiotic research in favor of more profitable long-term treatments for chronic conditions.
Super Gonorrhea Outbreak, Two Broke Girls Sitcom
A clip from the sitcom "Two Broke Girls" mentions "super gonorrhea," leading to a report on a real-world drug-resistant strain of the infection. New York Magazine reports on the rise of antibiotic-resistant cases, noting that the CDC is concerned about the effectiveness of current treatments.
The hosts examine the E. coli outbreak in Europe, specifically the Q104 strain, questioning its unique DNA sequences and high toxicity. They cite reports from Natural News suggesting the bacteria's antibiotic resistance may be the result of laboratory-based selective breeding rather than natural evolution.
